Docosahexaenoic acid decreases phospholipase A2 activity in the neurites/nerve growth cones of PC12 cells

Journal of Neuroscience Research

Volumn 54, Issue 6, 1998, Pages 805-813

  Martin, Rex E ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Docosahexaenoic acid; Neuronal development differentiation; Nutrition; Omega 3 (n 3) fatty acid; Phospholipase A

Indexed keywords

ARACHIDONIC ACID; CALCIUM; CARBON 14; DOCOSAHEXAENOIC ACID; GLYCEROLIPID; NERVE GROWTH FACTOR; PHOSPHOLIPASE A2; TRITIUM;

ANIMAL CELL; ARTICLE; BRAIN ISCHEMIA; CELL FRACTIONATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DENATURATION; ESTERIFICATION; GROWTH CONE; LONG TERM POTENTIATION; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NERVE FIBER GROWTH; NEUROPROTECTION; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; RAT;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; DOCOSAHEXAENOIC ACIDS; ETHANOLAMINES; GROWTH CONES; NEURITES; PC12 CELLS; PHOSPHOLIPASES A; RATS;

EID: 0032534624     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19981215)54:6<805::AID-JNR8>3.0.CO;2-4     Document Type: Article

References (49)

1. Agostoni C, Riva E, Trojan S, Bellù R, Giovannini M. 1995a. Docosahexaenoic acid status and developmental quotient of healthy term infants. Lancet 346:638.
2. Agostoni C, Trojan S, Bellù R, Riva E, Giovannini M. 1995b. Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: The role of long chain polyunsaturated fatty acids. Pediatric Res 38:262-266.
3. 2 inhibit release of free arachidonate in thrombin-stimulated human platelets. J Biol Chem 269:15625-15630.
4. Bazan NG. 1970. Effects of ischemia and electroconvulsive shock of free fatty acid pools in the brain. Biochem. Biophys. Acta 218:1-10.
5. Bazan NG. 1990. Supply of n-3 polyunsaturated fatty acids and their significance in the central nervous system. In: Wurtman RJ, Wurtman JJ, editors. Nutrition and the brain, volume 8. New York: Raven Press. p 1-24.
6. 2 and release of arachidonic acid and other lipid mediators at the synapse: The role of platelet-activating factor. J Lipid Mediators 6:421-427.
7. Bazan NG, Rodriguez de Turco EB, Allan GA. 1996. Mediators of injury in neurotrauma: Intracellular signal transduction and gene expression. J Neurotrauma 12:791-814.
8. Bradford M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
9. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. 1980a. Intrauterine fatty acid accretion rates in human brain: Implications for fatty acid requirements. Early Hum Dev 4:121-129.
10. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. 1980b. Extrauterine fatty acid accretion in infant brain: Implications for fatty acid requirements. Early Hum Dev 4:131-138.
11. Clark GD, Happel LT, Zorumski CF, Bazan NG. 1992. Enhancement of hippocampal excitatory synaptic transmission by platelet activating factor. Neuron 9:1211-1216.
12. 2 and its role in brain tissue. J Neurochem 69:889-901.
13. Fliesler SJ, Anderson RE. 1983. Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res 22:79-131.
14. Fujimoto K, Kanno T, Koga K, Ondera H, Hirno M, Nishikawa M, Maruyama K. 1993. Effects of n-3 fatty acid deficiency during pregnancy and lactation on learning ability in rats. In: Yasugi T, Nakamura H, Soma M, editors. Advances in polyunsaturated fatty acid research. Amsterdam: Elsevier. p 257-260.
15. Greene LA, Tischler AS. 1982. PC12 pheochromocytoma cultures in neurobiological research. Adv Cell Neurobiol 3:373-414.
16. Greene LA, Aletta JM, Rukenstein A, Green SH. 1987. PC12 pheochromocytoma cells: Culture, nerve growth factor treatment, and experimental exploitation. Meth Enzymol 147:207-216.
17. 2. Agents Actions 39:C39-C42.
18. Innis SM. 1991. Essential fatty acids in growth and development. Prog Lipid Res 30:39-103.
19. Kato K, Clark GD, Bazan NG, Zorumski CF. 1994. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature 367:175-179.
20. Kausner K, Clark JE, Masters BS, Ortiz de Montellano PR, Ma YH, Harder DR, Roman RJ. 1991. Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries. Circ Res 68:1154-1163.
21. Luthria DL, Mohammed BS, Sprecher H. 1996. Regulation of the biosynthesis of 4, 7, 10, 13, 16, 19-docosahexaenoic acid. J Biol Chem 271:16020-16025.
22. 2. Agents Actions 34:106-109.
23. Martin RM, Bazan NG. 1992. Changing fatty acid content of growth cone lipids prior to synaptogenesis. J Neurochem 59:318-325.
24. Martin RE, Wickham JQ. 1996. Membrane docosahexaenoic acid content influences A-type phospholipase activity in PC12 cell nerve growth cones. Soc Neurosci Abst 22:37.
25. Martin RE, Rodriguez de Turco EB, Bazan NG. 1994. Developmental maturation of hepatic n-3 polyunsaturated fatty acid metabolism: Supply of docosahexaenoic acid to retina and brain. J Nutr Biochem 5:151-160.
26. Martinez M. 1992. Tissue levels of polyunsaturated fatty acids during early human development. J Ped 120:S129-S138.
27. 2 from rat neuronal cells and its possible function in regulation of catecholamine secretion. Biochem J 318:701-709.
28. 2(S): Comparison of arachidonyl-selective and -nonselective enzymes. FASEB J 7:339-348.
29. 2 activity in nerve growth cones. J Neurochem 60:1126-1136.
30. 2 activity enriched in the nerve growth cone. J Neurochem 67:2599-2608.
31. Okada M, Amamoto T, Tomonaga M, Kawachi A, Yazawa K, Mine K, Fujiwara M .1996. The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats. Neuroscience 71:17-25.
32. Pfenninger KH, Johnson MP. 1983. Membrane biogenesis in the sprouting neuron. I. Selective transfer of newly synthesized phospholipid into the growing neurite. J Cell Biol 97:1038-1042.
33. Pfenninger KH, Ellis L, Johnson MP, Friedman LB, Somlo S. 1983. Nerve growth cones isolated from fetal retina brain: Subcellular fractionation and characterization. Cell 35: 573-584.
34. Posse de Chaves E, Vance DE, Campenot RB, Vance JE. 1995. Axonal synthesis of phosphatidylcholine is required for normal axonal growth in rat sympathetic neurons. J Cell Biol 128:913-918.
35. Relton JK, Strijbos PJLM, Cooper AL, Rothwell NJ. 1993. Dietary N-3 fatty acids inhibit ischaemic and excitotoxic brain damage in the rat. Brain Res Bull 32:223-226.
36. Riendeau D, Guay J, Weech PK, Laliberte F, Yergey J, Li C, Desmarais S, Perrier H, Liu S, Nicoll-Griffith D. 1994. Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J Biol Chem 269:15619-15624.
37. Rodriguez de Turco EB, Gordon W, Bazan NG. 1991. Rapid and selective uptake, metabolism, and differential distribution of docosahexaenoic acid among rod and cone photoreceptor cells in the frog retina. J Neurosci 11:3667-3678.
38. Rotstein NP, Aveldaño MI, Barrantes FJ, Politi LE. 1996. Docosahexaenoic acid is required for the survival of rat retinal photoreceptors in vitro. J Neurochem 66:1851-1859.
39. Rouser G, Fleischer S, Yamamoto A. 1970. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5:494-496.
40. Salem N, Niebylski CD. 1995. The nervous system has an absolute molecular species requirement for proper function. Mol Memb Biol 12:131-134.
41. Salem N, Kim H-Y, Yergey JA. 1986. Docosahexaenoic acid: Membrane function and metabolism. In Simopoulos AP, Kifer RR, Martin RE, editors. Health effects of polyunsaturated fatty acids in seafoods. New York: Academic Press Inc. p 263-317.
42. Simopoulos AP. 1991. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 54:438-463.
43. Sobue K, Kanda K. 1989. α-actinins, calspectin (brain spectrin or fondrin), and actin participate in adhesion and movement in growth cones. Neuron 3:311-319.
44. 2. Biochemistry 32:5935-5940.
45. Sun GY, Sun AY. 1972. Phospholipids and acyl groups of synaptosomal and myelin membranes isolated from the cerebral cortex of squirrel monkey (Saimiri sciureus). Biochim Biophys Acta 280:306-315.
46. Sun GY, Su KL, Der OM, Tang W. 1978. Enzymatic regulation of arachidonate metabolism in brain membrane phosphoglycerides. Lipids 14:229-235.
47. Voss A, Reinhart M, Sankarappa S, Sprecher H. 1991. The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,14,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. J Biol Chem 266:19995-20000.
48. Wieraszko A, Li G, Kornecki E, Hogan MV, Ehrlich YH. 1993. Long-term potentiation in the hippocampus induced by platelet-activating factor. Neuron 10:553-557.
49. Zerouga M, Stillwell W, Stone J, Powner A, Jenski LJ. 1996. Phospholipid class as a determinant in docosahexaenoic acid's effect on tumor cell viability. Anticancer Res 16:2863-2868.